Work

Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia

Year: 2005

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.01.0033

Authors: Ching-Hon Pui, Deqing Pei, John T. Sandlund, Dario Campana, Raul C. Ribeiro, Bassem I. Razzouk, Jeffrey E. Rubnitz, Scott C. Howard, Nobuko Hijiya, Sima Jeha, Cheng Cheng, James R. Downing, William E. Evans, Mary V. Relling, Melissa Hudson

Institutions: St. Jude Children's Research Hospital, University of Tennessee Health Science Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences

Awards: G1281835685, G1322097379, G1756836520, G2218658011, Detection and Therapy of Residual Leukemia in Children, G609259107, PAAR-Pharmacogenomics of Anticancer Agents Research Group, PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN, PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL), G883648719, Cancer Center Support Grant (CCSG), Anticancer Agent Pharmacodynamics in Acute Leukemia

OpenAlex ID: W2107317577

FWCI: 5.496

Cites: 42

Cited by: 72

Related to: 10